{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:00:30Z","timestamp":1792461630640,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013347","name":"European Society of Intensive Care Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eclinm.2025.103300","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:00:22Z","timestamp":1751356822000},"page":"103300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Advocating for the recognition of underlying immunosuppression in critical illness"],"prefix":"10.1016","volume":"85","author":[{"given":"Ignacio","family":"Martin-Loeches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Kreitmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Puxty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Santos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Vagos","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-1232","authenticated-orcid":false,"given":"Ben","family":"Creagh-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6118-8970","authenticated-orcid":false,"given":"Pedro","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-1453","authenticated-orcid":false,"given":"Jorge","family":"Salluh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Vidaur-Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8162-1508","authenticated-orcid":false,"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13613-024-01314-1","article-title":"Immunosuppression at ICU admission is not associated with a higher incidence of ICU-acquired bacterial bloodstream infections: the COCONUT study","volume":"14","author":"Zebian","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13054-023-04626-z","article-title":"Long-term immunosuppressive treatment is not associated with worse outcome in patients hospitalized in the intensive care unit for septic shock: the PACIFIC study","volume":"27","author":"Vaidie","year":"2023","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/WCO.0b013e328346d47d","article-title":"Managing the risks of immunosuppression","volume":"24","author":"Riminton","year":"2011","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103300_bib4","doi-asserted-by":"crossref","first-page":"e1397","DOI":"10.1093\/cid\/ciab397","article-title":"Improving the outcomes of immunocompromised patients with coronavirus disease 2019","volume":"73","author":"Haidar","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103300_bib5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s00134-023-07210-9","article-title":"European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00134-022-06954-0","article-title":"Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study","volume":"49","author":"Kreitmann","year":"2023","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13054-018-2076-z","article-title":"Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data","volume":"22","author":"Georges","year":"2018","journal-title":"Crit Care"},{"issue":"13","key":"10.1016\/j.eclinm.2025.103300_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133196","article-title":"Comparison of short- and long-term mortality in patients with or without cancer admitted to the ICU for septic shock: a retrospective observational study","volume":"14","author":"Le Borgne","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib9","first-page":"1325","article-title":"Long-term prognosis of septic shock in cancer patients","volume":"28","author":"Camou","year":"2020","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib10","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/CCM.0000000000002722","article-title":"Time course of septic shock in immunocompromised and nonimmunocompromised patients","volume":"45","author":"Jamme","year":"2017","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1378\/chest.13-2618","article-title":"Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile","volume":"146","author":"Tolsma","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01656-2017","article-title":"Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections","volume":"51","author":"Moreau","year":"2018","journal-title":"Eur Respir J"},{"issue":"15","key":"10.1016\/j.eclinm.2025.103300_bib13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103300_bib14","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103300_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0026-2016","article-title":"Overview of infections in the immunocompromised host","volume":"4","author":"Dropulic","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103300_bib16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients","volume":"68","author":"Di Pasquale","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-2600(18)30345-X","article-title":"Acute respiratory failure in immunocompromised adults","volume":"7","author":"Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.202009-3575OC","article-title":"Survival in immunocompromised patients ultimately requiring invasive mechanical ventilation: a pooled individual patient data analysis","volume":"204","author":"Dumas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 Suppl 2","key":"10.1016\/j.eclinm.2025.103300_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.eclinm.2025.103300_bib20","series-title":"Cellular and molecular immunology","author":"Abbas","year":"1991"},{"key":"10.1016\/j.eclinm.2025.103300_bib21","series-title":"Janeway's immunobiology\/kenneth murphy, casey weaver ; with contributions by Allan Mowat, Leslie Berg, David Chaplin ; with acknowledgment to Charles A. Janeway Jr., Paul Travers, mark Walport","author":"Murphy","year":"2017"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13054-024-05099-4","article-title":"Lymphopenia in sepsis: a narrative review","volume":"28","author":"Wang","year":"2024","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib23","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1373\/clinchem.2005.052639","article-title":"Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study","volume":"51","author":"D\u00f6cke","year":"2005","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cyto.b.21987","article-title":"A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials","volume":"100","author":"Quadrini","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.eclinm.2025.103300_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection risk and safety of corticosteroid use","volume":"42","author":"Youssef","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11051119","article-title":"Multi-omics endotypes in ICU sepsis-induced immunosuppression","volume":"11","author":"Garduno","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13613-020-00764-7","article-title":"Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status","volume":"10","author":"Mokart","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/CCM.0000000000006050","article-title":"National ICU registries as enablers of clinical research and quality improvement","volume":"52","author":"Salluh","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eclinm.2025.103300_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcrc.2020.08.031","article-title":"Linking of global intensive care (LOGIC): an international benchmarking in critical care initiative","volume":"60","author":"Dongelmans","year":"2020","journal-title":"J Crit Care"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103300_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","article-title":"Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine","volume":"12","author":"Cajander","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13613-024-01323-0","article-title":"Biomarkers in pulmonary infections: a clinical approach","volume":"14","author":"P\u00f3voa","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s13054-020-03219-4","article-title":"The importance of airway and lung microbiome in the critically ill","volume":"24","author":"Martin-Loeches","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00109-022-02193-4","article-title":"Clinical perspectives on the age-related increase of immunosuppressive activity","volume":"100","author":"Salminen","year":"2022","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103300_bib38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103300_bib39","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/598624","article-title":"New trends in patient management: risk-based therapy for febrile patients with neutropenia","volume":"29","author":"Rolston","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib41","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103300_bib42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13054-022-04170-2","article-title":"Relationship between corticosteroid use and incidence of ventilator-associated pneumonia in COVID-19 patients: a retrospective multicenter study","volume":"26","author":"Saura","year":"2022","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib44","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research","volume":"19","author":"Rubio","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103300_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1498974","article-title":"Time-dependent variation in immunoparalysis biomarkers among patients with sepsis and critical illness","volume":"15","author":"Samuelsen","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103300_bib46","article-title":"A machine learning approach to determine risk factors for respiratory bacterial\/fungal coinfection in critically ill patients with influenza and SARS-CoV-2 infection: a Spanish perspective","volume":"13","author":"Rodr\u00edguez","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103300_bib47","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","article-title":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure","volume":"174","author":"Felmet","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10495-016-1325-3","article-title":"Apoptosis-induced lymphopenia in sepsis and other severe injuries","volume":"22","author":"Girardot","year":"2017","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/cc11157","article-title":"Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern","volume":"16","author":"Heffernan","year":"2012","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103300_bib50","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","article-title":"Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock","volume":"36","author":"Landelle","year":"2010","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13613-022-01010-y","article-title":"Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with secondary infections","volume":"12","author":"de Roquetaillade","year":"2022","journal-title":"Ann Intensive Care"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103300_bib52","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","article-title":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock","volume":"32","author":"Monneret","year":"2006","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13613-022-01051-3","article-title":"A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score","volume":"12","author":"Tremblay","year":"2022","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.eclinm.2025.103300_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.930043","article-title":"Mortality prediction in sepsis with an immune-related transcriptomics signature: a multi-cohort analysis","volume":"9","author":"Kreitmann","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.eclinm.2025.103300_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1100352","article-title":"Leveraging transcriptomics for precision diagnosis: lessons learned from cancer and sepsis","volume":"14","author":"Tsakiroglou","year":"2023","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib56","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2215\/CJN.07130622","article-title":"Overview of the medical management of the critically ill patient","volume":"17","author":"Martinez","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.eclinm.2025.103300_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154137","article-title":"Immunotherapy to treat sepsis induced-immunosuppression: immune eligibility or outcome criteria, a systematic review","volume":"72","author":"Borouchaki","year":"2022","journal-title":"J Crit Care"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib58","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.eclinm.2025.103300_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1041010","article-title":"Hematologic dysfunction in cancer: mechanisms, effects on antitumor immunity, and roles in disease progression","volume":"13","author":"Plackoska","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13613-018-0361-2","article-title":"The effect of a medication reconciliation program in two intensive care units in The Netherlands: a prospective intervention study with a before and after design","volume":"8","author":"Bosma","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103300_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12112712","article-title":"Invasive aspergillosis in the intensive care unit","volume":"12","author":"Townsend","year":"2022","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103300_bib62","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91135-0","article-title":"The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation","volume":"11","author":"Tsai","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103300_bib64","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1086\/503435","article-title":"The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review","volume":"193","author":"Eckmanns","year":"2006","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103300_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12094-022-02800-3","article-title":"SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)","volume":"24","author":"Echavarria","year":"2022","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib66","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/ciu789","article-title":"Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study","volume":"60","author":"Kalil","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00007890-199401000-00023","article-title":"Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation","volume":"57","author":"Ma\u00f1ez","year":"1994","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103300_bib68","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00002018-200225100-00003","article-title":"Drug interactions with tacrolimus","volume":"25","author":"van Gelder","year":"2002","journal-title":"Drug Saf"},{"issue":"30","key":"10.1016\/j.eclinm.2025.103300_bib69","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103300_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101190","article-title":"Antifungal prophylaxis and pre-emptive therapy: when and how?","volume":"92","author":"Sprute","year":"2023","journal-title":"Mol Aspects Med"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103300_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103300_bib72","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","article-title":"Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the guidelines of the infectious diseases working party (AGIHO) of the German society for hematology and medical Oncology (DGHO)","volume":"94","author":"Sandherr","year":"2015","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/COC.0b013e318209aa41","article-title":"Herpesviridae viral infections after chemotherapy without antiviral prophylaxis in patients with malignant lymphoma: incidence and risk factors","volume":"35","author":"Lee","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103300_bib74","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.2147\/IDR.S420244","article-title":"Cytomegalovirus pneumonia in inflammatory bowel disease: literature review and clinical recommendations","volume":"16","author":"Ren","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103300_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112666","article-title":"Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmi.2024.01.005","article-title":"Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"30","author":"Biyun","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"10.1016\/j.eclinm.2025.103300_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib79","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103300_bib80","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia","volume":"2014","author":"Mhaskar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib81","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","article-title":"ICU-acquired infections in immunocompromised patients","volume":"50","author":"Kreitmann","year":"2024","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib82","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13613-023-01125-w","article-title":"Necrotizing soft tissue infections in critically ill neutropenic patients: a French multicentre retrospective cohort study","volume":"13","author":"Arrestier","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103300_bib85","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00134-002-1528-7","article-title":"Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients","volume":"28","author":"Darmon","year":"2002","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib86","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1080\/10428194.2018.1516874","article-title":"Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies","volume":"60","author":"Mignard","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"10.1016\/j.eclinm.2025.103300_bib87","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103300_bib88","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cncr.21142","article-title":"Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia","volume":"104","author":"Dignani","year":"2005","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103300_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103300_bib90","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/phar.2718","volume":"42","author":"Nelson","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103300_bib91","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/TP.0000000000004776","article-title":"Comparison of 2 immunosuppression minimization strategies in kidney transplantation: the ALLEGRO trial","volume":"108","author":"van den Born","year":"2024","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103300_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13550","article-title":"Evaluation of Quantiferon\u00ae-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients","volume":"23","author":"Gardiner","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103300_bib94","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MOT.0000000000000771","article-title":"Recent advances in precision medicine for individualized immunosuppression","volume":"25","author":"Fu","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.eclinm.2025.103300_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1168400","article-title":"Understanding torquetenovirus (TTV) as an immune marker","volume":"10","author":"Gore","year":"2023","journal-title":"Front Med"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103300_bib96","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3899\/jrheum.220881","article-title":"Restoring balance: immune tolerance in rheumatoid arthritis","volume":"50","author":"Kaur","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.eclinm.2025.103300_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101731","article-title":"Correcting inborn errors of immunity: from viral mediated gene addition to gene editing","volume":"66","author":"Castiello","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.eclinm.2025.103300_bib98","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3389\/fimmu.2018.01926","article-title":"Precision immunotherapy for sepsis","volume":"9","author":"Peters van Ton","year":"2018","journal-title":"Front Immunol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025002329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025002329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:39:08Z","timestamp":1768829948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025002329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":98,"alternative-id":["S2589537025002329"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103300","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advocating for the recognition of underlying immunosuppression in critical illness","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103300"}}